Drug Trial Radar · NCT05836740
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: May 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,724
Actual
Start
May 19, 2023
Primary completion
May 20, 2024
Study completion Aug 15, 2024
Sponsor
- Lead sponsor
- Beijing Tiantan HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Neurodawn Pharmaceutical Co., Ltd.
- First posted
- May 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study was to evaluate the efficacy and safety of Minocycline versus placebo in the treatment of patients with moderate to severe acute ischemic stroke.
Conditions
- Ischemic Stroke, Acute
Interventions
Minocycline hydrochloride capsuleDrug
50 mg per capsule, containing 50mg of Minocycline Hydrochloride.
Placebo capsules of Minocycline hydrochloride capsulesDrug
50 mg per capsule, containing 0mg of Minocycline Hydrochloride.
Primary outcomes
What the sponsor says the trial is designed to measure.
- mRS score 0-1Time frame: At 90±7 days after randomization.
Locations
58 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tiantan Hospital
Beijing, China
Ningjin People's Hospital
Dezhou, China
Zouping City People's Hospital
Jining, China
The Eighth Medical Center of PLA General Hospital
Beijing, Beijing Municipality, China
Beijing Shunyi Hospital
Beijing, Beijing Municipality, China
Chongqing Donghua Hospital
Chongqing, Chongqing Municipality, China
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, China
Shenzhen Hospital, Southern Medical University
Shenzhen, Guangdong, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
The Second Nanning People's Hospital
Nanning, Guangxi, China
The Sixth People's Hospital of Hengshui
Hengshui, Hebei, China
North China University of Science and Technology Affiliated Hospital
Tangshan, Hebei, China
Dengzhou People's Hospital
Dengzhou, Henan, China
Xiuwu People's Hospital
Jiaozuo, Henan, China
Jiyuan Chinese Medical Hospital
Jiyuan, Henan, China
Luoyang Central Hospital
Luoyang, Henan, China
Mengjin People's Hospital
Luoyang, Henan, China
Luoning People's Hospital
Luoyang, Henan, China
Mengzhou People's Hospital
Mengzhou, Henan, China
Nanle Zhongxing Hospital
Puyang, Henan, China
Sui Chinese Medical Hospital
Shangqiu, Henan, China
Xingyang People's Hospital
Zhengzhou, Henan, China
Biyang People's Hospital
Zhumadian, Henan, China
Pingyu People's Hospital
Zhumadian, Henan, China
Wuhan No.1 Hospital
Wuhan, Hubei, China
Shimen People's Hospital
Changde, Hunan, China
Xiangya Hospital, Central South University
Changsha, Hunan, China
The First People's Hospital of Chenzhou/The First Affiliated Hospital of Xiangnan University
Chenzhou, Hunan, China
Hengyang Central Hospital
Hengyang, Hunan, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
Changzhou Wujin Traditional Chinese Medicine Hospital
Changzhou, Jiangsu, China
Rudong People's Hospital
Nantong, Jiangsu, China
The Fourth Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Jiujiang University Affiliated Hospital
Jiujiang, Jiangxi, China
China-Japan Union Hospital of Jilin University
Changchun, Jilin, China
Benxi Central Hospital
Benxi, Liaoning, China
The First Affiliated Hospital of Jinzhou Medical University
Jinzhou, Liaoning, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Affiliated Hospital of Jining Medical University
Jining, Shandong, China
Showing 40 of 58 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.